Remix Therapeutics Announces Participation in Jefferies London Healthcare Conference
Press Releases
Remix Therapeutics  
October 29, 2024

Remix Therapeutics Announces Participation in Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Oct. 29, 2024 /PRNewswire/ -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today

avatar profile Olean Times Herald

Olean Times Herald


Local & Social